Novo CEO pressed by Senate to cut charges of being overweight, diabetes medicines CEO Lars Fruergaard Jørgensen explained to lawmakers the corporation would think about new talks with insurers concerning the listing price ranges of Wegovy and copyright if they pledge to help keep the medicines on their formularies. Sanders https://kethek.com/